by Paul Sax
We published a plain case: Clinically sturdy HIV+ gay man, on HIV treatment; anal pap comes back with “atypical squamous cells of undetermined import” (ASCUS).
What to do with this denouement? Two experts weighed in , Howard Libman and Joel Paladin. In Howard’s engrossed reply, he acknowledges the limitations of the facts thus far, but said he would refer the invalid for peak-persistence anoscopy (HRA) and biopsy — which is what most of our readers said as well.
But Joel acknowledges that, teeth of an institutional authority to refer all such patients, he wavers a bit for those with ASCUS:
I have been bending the rules in patients with ASCUS and monitoring them with once a year Pap smears rather than referring them for HRA. I do this with the competence that the Pap wipe provides an hazy dimension of the firm rating of dysplasia and that those with ASCUS could have higher grades on biopsy. However, I have to weigh that danger with the actually that my patients don’t take advantage of wealthy through HRA, biopsy, and ablation, that the parallels between anal and cervical dysplasia aren’t through-and-through, and that the protocols around anal Pap calumniate are written without much demonstrate subsidy them up.
...
Read more...